Baluba, Shainne .
HRN: 16-55-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2024
CEFUROXIME 1.5GM (VIAL)
12/03/2024
12/10/2024
INTRAVENOUS
570 Mg
Every 8 Hours
Acute Tonsillopharyngitis, PCAP-A
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes